Radiation Therapy News and Research

RSS

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.

Researchers identify, validate three distinct molecular subtypes of prostate cancer

In the largest study of its kind to date, researchers have identified and validated three distinct molecular subtypes of prostate cancer that correlate with distant metastasis-free survival and can assist in future research to determine how patients will respond to treatment, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

Increased use of SBRT linked to improved survival outcomes of NSCLC patients

A new analysis of records in the Veteran's Affairs Central Cancer Registry demonstrates a clear positive impact of the increased use of stereotactic body radiation therapy (SBRT) to treat patients with stage I non-small cell lung cancer (NSCLC) in recent years, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

Approval of PD-1 inhibitor scratches surface of potential immunotherapies in recurrent HNSCC

The recent approval of pembrolizumab (Keytruda) in recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) following progression on a platinum-based chemotherapy was a significant advancement for the disease.

26 Sep 2016

Concord Medical's first proton therapy center to be installed at Beijing Proton Medical Center

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, is pleased to announce that its subsidiary, Medstar Leasing Co., Ltd, has signed a contract with IBA for the purchase, installation and maintenance of a proton therapy system, which will be installed at Beijing Proton Medical Center.

26 Sep 2016

Qfix launches new Symphony Patient Transport System to safely increase workflow efficiencies

Today, Qfix, a world leader in radiotherapy patient positioning devices, announced it is launching the new Symphony Patient Transport System that maximizes workflow efficiencies and throughput by seamlessly aiding in the setup, positioning and transfer of a patient for procedures involving imaging, external beam radiation therapy, brachytherapy and other procedures requiring the transfer of a patient.

26 Sep 2016

Immune and targeted therapies may be beneficial in patients with melanoma brain metastases

Brain metastases are one of the most common complications of advanced melanoma, requiring multidisciplinary management.

21 Sep 2016

Leading cancer organizations publish new guidelines on postmastectomy radiotherapy

Three leading national cancer organizations today issued a joint clinical practice guideline update for physicians treating women with breast cancer who have undergone a mastectomy.

20 Sep 2016

TransOral Robotic Surgery may provide good outcomes, survival for oropharyngeal cancer patients

A new study from researchers at Henry Ford Hospital finds an incisionless robotic surgery - done alone or in conjunction with chemotherapy or radiation - may offer oropharyngeal cancer patients good outcomes and survival, without significant pain and disfigurement.

16 Sep 2016

Study underscores importance of joint treatment decisions between prostate cancer patients and doctors

In light of the findings from the Prostate Testing for Cancer and Treatment trial published yesterday in the New England Journal of Medicine, the American Society for Radiation Oncology would like to congratulate the authors and investigators for conceiving and completing a difficult clinical trial to randomize care for 2,664 men who volunteered to be a part of this study.

16 Sep 2016

Orlando Health to bring benefits of MRI-guided radiation therapy to Central Florida

Orlando Health will soon begin providing a new therapy that allows oncologists to see the tumor they are treating continuously during radiation therapy.

13 Sep 2016

Philips unveils innovative interventional oncology solution for liver cancer treatment at CIRSE 2016

Royal Philips today announced that it will unveil its latest innovation in interventional oncology at the 2016 Cardiovascular and Interventional Radiological Society of Europe annual meeting (CIRSE 2016), which will be held in Barcelona (Spain) from September 10 until 14.

13 Sep 2016

PSA failure linked to increased risk of death among healthy men

A new study by investigators at Brigham and Women's Hospital has found that a rise in prostate-specific antigen (PSA) levels in healthy men who have previously been treated for prostate cancer is significantly associated with a 1.6-fold increased risk of death.

6 Sep 2016

Research findings could lead to new biomarker for early stages of tumor development

To treat or not to treat? That is the question researchers at the Department of Energy's Lawrence Berkeley National Laboratory hope to answer with a new advance that could help doctors and their cancer patients decide if a particular therapy would be worth pursuing.

31 Aug 2016

Scripps collaborates with MD Anderson for clinically integrated cancer care program

Scripps Health and The University of Texas MD Anderson Cancer Center have reached a partnership agreement to create Scripps MD Anderson Cancer Center, a comprehensive and clinically integrated cancer care program in San Diego that will provide adult cancer patients greater access to the most advanced oncology care available throughout Southern California.

29 Aug 2016

NIBIB researchers develop nanovaccine to enhance cancer immunotherapy

NIBIB researchers have created a nanovaccine that could make a current approach to cancer immunotherapy more effective while also reducing side effects.

25 Aug 2016

Lack of insurance may increase risk of death in men with testicular cancer, study finds

Men with testicular cancer who were uninsured or on Medicaid had a higher risk of death from what is normally a curable disease than insured patients, a new study found.

8 Aug 2016

Studies show insurance status may impact patients' health outcomes following cancer diagnosis

Two new studies indicate that health insurance status may impact patients' health outcomes following a diagnosis of cancer.

8 Aug 2016

Scientists develop novel multifunctional platform to integrate imaging and photo-induced cancer therapy

Physicists from The University of Texas at Arlington are leading a multidisciplinary project with The University of Texas Southwestern Medical Center in Dallas and The University of Texas MD Anderson Cancer Center in Houston to develop a new multifunctional platform that can integrate imaging and photo-induced cancer therapy in a single, portable device.

5 Aug 2016

African-American men treated with ADT for prostate cancer suffer from high mortality rates

In a retrospective study analyzing patients' medical records, researchers at Brigham and Women's Hospital found that patients' race significantly affected their longevity by increasing the likelihood of death after receiving androgen deprivation therapy (ADT).

5 Aug 2016

Researchers develop method to kill cancer cells using nanoparticles and lasers

Cancer treatments based on laser irridation of tiny nanoparticles that are injected directly into the cancer tumor are working and can destroy the cancer from within.

4 Aug 2016

Radiation Therapy News and Research

Further Reading

Researchers identify, validate three distinct molecular subtypes of prostate cancer

Increased use of SBRT linked to improved survival outcomes of NSCLC patients

Approval of PD-1 inhibitor scratches surface of potential immunotherapies in recurrent HNSCC

Concord Medical's first proton therapy center to be installed at Beijing Proton Medical Center

Qfix launches new Symphony Patient Transport System to safely increase workflow efficiencies

Immune and targeted therapies may be beneficial in patients with melanoma brain metastases

Leading cancer organizations publish new guidelines on postmastectomy radiotherapy

TransOral Robotic Surgery may provide good outcomes, survival for oropharyngeal cancer patients

Study underscores importance of joint treatment decisions between prostate cancer patients and doctors

Orlando Health to bring benefits of MRI-guided radiation therapy to Central Florida

Philips unveils innovative interventional oncology solution for liver cancer treatment at CIRSE 2016

PSA failure linked to increased risk of death among healthy men

Research findings could lead to new biomarker for early stages of tumor development

Scripps collaborates with MD Anderson for clinically integrated cancer care program

NIBIB researchers develop nanovaccine to enhance cancer immunotherapy

Lack of insurance may increase risk of death in men with testicular cancer, study finds

Studies show insurance status may impact patients' health outcomes following cancer diagnosis

Scientists develop novel multifunctional platform to integrate imaging and photo-induced cancer therapy

African-American men treated with ADT for prostate cancer suffer from high mortality rates

Researchers develop method to kill cancer cells using nanoparticles and lasers

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News